CEFAZOLINE PANPHARMA 1 g, powder for solution for injection/for infusion 10 bottles of 15 ml
Active ingredients: Cefazolin, Cefazolin sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection or infusion10 bottles of 15 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFAZOLINE PANPHARMA 1 g, poudre pour solution injectable/pour perfusion
- Pharmaceutical form
- poudre pour solution injectable ou pour perfusion
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 10 flacon(s) en verre de 15 ml
- Marketing authorisation holder
- PANPHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61876894CIP73027067CIP133400930270677Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFAZOLINE SODIQUEpoudre | 1,048 g · un flacon | SA |
| CÉFAZOLINEpoudre | 1 g · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.